Phase 1 Updated Exploration and First Expansion Data for DLL3-targeted T-cell Engager Tarlatamab in Small Cell Lung Cancer

Borghaei, H; Paz-Ares, L; Johnson, M; Champiat, S; Owonikoko, T; Lai, V; Boyer, M; Hummel, HD; Govindan, R; Steeghs, N; Blackhall, F; Reguart, N; Dowlati, A; Zhang, Y; Sadraei, NH; Goldrick, A; Izumi, H

JOURNAL OF THORACIC ONCOLOGY, 2022; 17 (9): S33